266 related articles for article (PubMed ID: 36131910)
1. Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond.
Pagliuca S; Gurnari C; Rubio MT; Visconte V; Lenz TL
Front Immunol; 2022; 13():944872. PubMed ID: 36131910
[TBL] [Abstract][Full Text] [Related]
2. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies.
Seliger B
HLA; 2016 Nov; 88(5):213-220. PubMed ID: 27659281
[TBL] [Abstract][Full Text] [Related]
4. Modulation of alloimmune response by commensal gut microbiota and potential new avenues to influence the outcome of allogeneic transplantation by modification of the 'gut culture'.
Kanangat S
Int J Immunogenet; 2017 Feb; 44(1):1-6. PubMed ID: 28044415
[TBL] [Abstract][Full Text] [Related]
5. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
[TBL] [Abstract][Full Text] [Related]
6. Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.
Soto-Nava M; Avila-Ríos S; Valenzuela-Ponce H; García-Morales C; Carlson JM; Tapia-Trejo D; Garrido-Rodriguez D; Alva-Hernández SN; García-Tellez TA; Murakami-Ogasawara A; ; Mallal SA; John M; Brockman MA; Brumme CJ; Brumme ZL; Reyes-Teran G;
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093100
[TBL] [Abstract][Full Text] [Related]
7. Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.
Han J; Dong Y; Zhu X; Reuben A; Zhang J; Xu J; Bai H; Duan J; Wan R; Zhao J; Bai J; Xia X; Yi X; Cheng C; Wang J; Wang Z
Nat Commun; 2024 Feb; 15(1):1199. PubMed ID: 38331912
[TBL] [Abstract][Full Text] [Related]
8. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
Kim CJ; Parkinson DR; Marincola F
J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
[TBL] [Abstract][Full Text] [Related]
9. HLA-G and immune evasion in cancer cells.
Sheu J; Shih IeM
J Formos Med Assoc; 2010 Apr; 109(4):248-57. PubMed ID: 20434034
[TBL] [Abstract][Full Text] [Related]
10. Involvement of HLA class I molecules in the immune escape of urologic tumors.
Carretero R; Gil-Julio H; Vázquez-Alonso F; Garrido F; Castiñeiras J; Cózar JM
Actas Urol Esp; 2014 Apr; 38(3):192-9. PubMed ID: 24315763
[TBL] [Abstract][Full Text] [Related]
11. MHC class I antigens, immune surveillance, and tumor immune escape.
Garcia-Lora A; Algarra I; Garrido F
J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
[TBL] [Abstract][Full Text] [Related]
12. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
[TBL] [Abstract][Full Text] [Related]
13. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA diversity with the risk of 25 cancers in the UK Biobank.
Wang QL; Wang TM; Deng CM; Zhang WL; He YQ; Xue WQ; Liao Y; Yang DW; Zheng MQ; Jia WH
EBioMedicine; 2023 Jun; 92():104588. PubMed ID: 37148584
[TBL] [Abstract][Full Text] [Related]
15. The binding profile of SARS-CoV-2 with human leukocyte antigen polymorphisms reveals critical alleles involved in immune evasion.
Zhan Y; Ye L; Ouyang Q; Yin J; Cui J; Liu K; Guo C; Zhang H; Zhai J; Zheng C; Guo A; Sun B
J Med Virol; 2023 Sep; 95(9):e29113. PubMed ID: 37750416
[TBL] [Abstract][Full Text] [Related]
16. Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion.
Jhunjhunwala S; Hammer C; Delamarre L
Nat Rev Cancer; 2021 May; 21(5):298-312. PubMed ID: 33750922
[TBL] [Abstract][Full Text] [Related]
17. HAMdetector: a Bayesian regression model that integrates information to detect HLA-associated mutations.
Habermann D; Kharimzadeh H; Walker A; Li Y; Yang R; Kaiser R; Brumme ZL; Timm J; Roggendorf M; Hoffmann D
Bioinformatics; 2022 Apr; 38(9):2428-2436. PubMed ID: 35238330
[TBL] [Abstract][Full Text] [Related]
18. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
[TBL] [Abstract][Full Text] [Related]
19. HLA Variation and SARS-CoV-2 Specific Antibody Response.
Wolday D; Fung CYJ; Morgan G; Casalino S; Frangione E; Taher J; Lerner-Ellis JP
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112884
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
